Effect of Migraine Headache on Productivity of Patients According to Migraine Disability Assessment Score: A Cross-Sectional Study
Tóm tắt
Migraine, a primary headache disorder, is usually recurrent with moderate to severe intensity. Migraine is the third most common cause of disability under the age of 50. There are various scoring systems for assessing this disability, one of which is MIDAS; the Migraine Disability Assessment Score. The objective of our study was to determine the extent of disability among migraine patients, patterns of prophylaxis, and their healthcare-seeking behaviors. This survey was done in 50 migraine patients at Jinnah postgraduate medical Centre from April to May 2018. The questionnaire inquired about the demographic information, management of migraine, and effect of this condition on their sleep, and the last part had assessment to know about their functional disability. The majority of the patients were females with a mean age of 31 ± 10 years. Acetaminophen was the most common medication used during a migraine attack, followed by nonsteroidal anti-inflammatory drugs. Only 54% of subjects admitted using prophylaxis, out of which 94% had stopped taking it after some time, with the most common reason being their side effects. β-blockers were the most common prophylaxis used. Only 32% had a regular follow-up visit with their doctors. Patients were graded according to the MIDAS score as: little or no disability, 22%; mild disability, 14%; moderate disability, 24%; and severe disability, 40%. The majority of migraine patients were found to have severe disability, which affected their daily work and social activities. Despite an increase in disability rate due to migraine, people do not seek regular medical care for this type of headache in Pakistan.
Tài liệu tham khảo
Aminoff RP, Simon DA, Greenberg MJ, editors. Clinical neurology. 7th ed. New York: Lange Medical Books/McGraw-Hill; 2009. p. 85–8.
World Health Organisation—Headache disorders Fact sheet No. 277. 2016.
Zandifar A, Asgari F, Haghdoost F, Masjedi SS, Manouchehri N, Banihashemi M, et al. Reliability and validity of the migraine disability assessment scale among migraine and tension type headache in Iranian patients. Biomed Res Int. 2014;2014:2014:978064. https://doi.org/10.1155/2014/978064.
Lipton RB, Stewart WF, Sawyer J, Edmeads JG. Clinical utility of an instrument assessing migraine disability: the migraine disability assessment (MIDAS) questionnaire. Headache J Head Face Pain. 2001;41(9):854–61.
Raggi A, Covelli V, Leonardi M, Grazzi L, Curone M, D’Amico D. Difficulties in work-related activities among migraineurs are scarcely collected: results from a literature review. Neurol Sci. 2014;35(1):23–6.
Baigi K, Stewart WF. Headache and migraine. a leading cause of absenteeism. Handb Clin Neurol. 2015;131:447–63. https://doi.org/10.1016/B978-0-444-62627-1.00025-1.
Herekar AA, Ahmad A, Uqaili UL, Ahmed B, Effendi J, Alvi SZ, et al. Primary headache disorders in the adult general population of Pakistan—a cross-sectional nationwide prevalence survey. J Headache Pain. 2017;18(1):28. https://doi.org/10.1186/s10194-017-0734-1.
Leonardi M, Steiner TJ, Scher AT, Lipton RB. The global burden of migraine: measuring disability in headache disorders with WHO’s Classification of Functioning, Disability and Health (ICF). J Headache Pain. 2005;6(6):429.
Yalinay Dikmen P, Yavuz BG, Aydinlar EI. The relationships between migraine, depression, anxiety, stress, and sleep disturbances. Acta Neurol Belg. 2015;115(2):117–22.
Stavem K, Kristiansen HA, Kristoffersen ES, Kværner KJ, Russell MB. Association of excessive daytime sleepiness with migraine and headache frequency in the general population. J Headache Pain. 2017;18(1):35.
Bendtsen L, Munksgaard SB, Tassorelli C, Nappi G, Katsarava Z, Lainez M, et al. Disability, anxiety and depression associated with medication-overuse headache can be considerably reduced by detoxification and prophylactic treatment. Results from a multicentre, multinational study (COMOESTAS project). Cephalalgia. 2014;34(6):426–33.
Murtaza M, Kisat M, Daniel H, Sonawalla AB. Classification and clinical features of headache disorders in Pakistan: a retrospective review of clinical data. PLoS One. 2009;4(6):e5827.
Noor T, Sajjad A, Asma A. Frequency, character and predisposing factor of headache among students of medical college of Karachi. J Pak Med Assoc. 2016;66(2):159–64.
Zahid M, Sthanadar AA, Kaleem M, Latif M, Sthanadar IA, Ali PA, Ismail M, Imtiaz N, Shah M. Prevalence and perceptions about migraine among students and patients in Khyber Pakhtunkhwa Province, Pakistan. Adv Biosci Biotechnol. 2014;5(6):508–16.
Stewart WF, Lipton RB, Dowson AJ, Sawyer J. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology. 2001;56(6 Suppl 1):S20–8.
García ML, Baos V, Láinez M, Pascual J, López-Gil A. Responsiveness of migraine-ACT and MIDAS questionnaires for assessing migraine therapy. Headache J Head Face Pain. 2008;48(9):1349–55.
Ghorbani A, Chitsaz A. Comparison of validity and reliability of the Migraine Disability Assessment (MIDAS) versus headache impact test (HIT) in an Iranian population. Iran J Neurol. 2011;10(3–4):39–42.
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edn. Cephalalgia. 2018;38(1):1–211.
Buse DC, Manack AN, Fanning KM, Serrano D, Reed ML, Turkel CC, et al. Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study. Headache. 2012;52(10):1456–70.
D’Amico D, Grazzi L, Curone M, Di Fiore P, Proietti Cecchini A, Leonardi M, et al. Difficulties in work activities and the pervasive effect over disability in patients with episodic and chronic migraine. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol. 2015;36(Suppl 1):9–11.
Park JW, Shin HE, Kim JS, Lee KS. Assessing migraine disability by diary-based measurement: relationship to the characteristics of individual headache attacks. Eur J Neurol. 2008;15(8):817–21.
Nagpal M, Jangid R, Sathyanarayan Rao T. A comparative study of the sexual functioning of women with primary headache in India. Indian J Psychiatry. 2018;60(2):224–8. https://doi.org/10.4103/psychiatry.IndianJPsychiatry_290_17.
Blumenfeld AM, Bloudek LM, Becker WJ, Buse DC, Varon SF, Maglinte GA, et al. Patterns of use and reasons for discontinuation of prophylactic medications for episodic migraine and chronic migraine: results from the second international burden of migraine study (IBMS-II). Headache. 2013;53(4):644–55.
Martelletti P. Floating out migraine disability thickened by medication overuse. Eur J Neurol. 2018;25(10):1193–4. https://doi.org/10.1111/ene.13736.
Usai S, Grazzi L, Andrasik F, D’Amico D, Rigamonti A, Bussone G. Chronic migraine with medication overuse: treatment outcome and disability at 3 years follow-up. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol. 2004;25(Suppl 3):S272–3.
Holland S, Fanning KM, Serrano D, Buse DC, Reed ML, Lipton RB. Rates and reasons for discontinuation of triptans and opioids in episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) study. J Neurol Sci. 2013;326(1–2):10–7.